Evidence map›Paper›PMID 31020065›Full record

ArticleEuropean heart journal. Case reports2017

Association between ibrutinib and mid-cavitary Takotsubo cardiomyopathy: a case report and a review of chemotherapy-induced Takostubo's cardiomyopathy.

Dana Elena Giza, Rohit Moudgil, Juan Lopez-Mattei, Peter Kim, Cezar Iliescu

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal. Case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dana Elena GizaDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, 77030 TX, USA.
Rohit MoudgilDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, 77030 TX, USA.
Juan Lopez-MatteiDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, 77030 TX, USA.
Peter KimDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, 77030 TX, USA.
Cezar IliescuDepartment of Cardiology, The University of Texas MD Anderson Cancer Center, 1400 Pressler Street, Houston, 77030 TX, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Takotsubo cardiomyopathy (TC) is a rare but increasingly recognized phenomenon, which can occur as a side effect of cancer treatment. We report an interesting case of a 53-year-old woman with non-small-cell lung cancer, who developed TC after chemotherapy with ibrutinib. Echocardiography revealed marked left ventricular dysfunction with apical hyperkinesis and mid-ventricular hypokinesia. Coronary angiogram was normal but did show mid-cavitary akinesis. To our knowledge, this is the first case of TC with ibrutinib. Therefore, TC remains a rare entity, and we present an elegant case of ibrutinib-mediated mid-cavitary Takotsubo cardiomyopathy with a literature review.

Indexed as

CancerCase reportIbrutinibStress-induced cardiomyopathyTakotsubo

Identifiers

PMID31020065
PMCPMC6177044
OpenAlexW2766591309

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.